RDHL Redhill Biopharma Ltd. - American Depositary Shares
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Apr 27, 2026
$0.50
· of 52w range
· above low
· to high
$0.4752w low
$2.2652w high
EPS
$0.00
Revenue
$286.0K
your badges
52W Range
$0–$2
Analyst Rating
BUY
Price Target
·
P/E
·
ROE
206.8%
Net Profit Margin
-150.0%
Your badge strip is empty — pin a metric anywhere on this page.
RDHL Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.50
EPS
$0.00
Revenue
$286.0K
ROE
206.8%
52W Range
$0–$2
RDHL Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Aug. 20, 2024 | 1-for-25 | Reverse |
| March 23, 2023 | 1-for-40 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$286.0K2016-12-31 → 2025-12-31
EPS$0.002016-12-31 → 2025-12-31
Free Cash Flow$-10M2017-12-31 → 2025-12-31
Net margin-150.0%2017-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | RDHL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin | -2776.9%5Y avg ≈-585.8% | ≈-585.8% | · | · | |
| EBITDA Margin | -2776.9%5Y avg ≈-585.8% | ≈-585.8% | · | · | |
| Net Profit Margin | -150.0%5Y avg ≈-23.3% | ≈-23.3% | · | · | |
| ROA | -2.0%5Y avg ≈-22.4% | ≈-22.4% | · | · | |
| ROE | 206.8%5Y avg ≈47.8% | ≈47.8% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | RDHL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 0.35Y avg ≈0.6 | ≈0.6 | · | · | |
| Quick Ratio | 0.15Y avg ≈0.3 | ≈0.3 | · | · | |
| Interest Coverage | -5.55Y avg ≈-3.4 | ≈-3.4 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | RDHL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.05Y avg ≈0.3 | ≈0.3 | · | · | |
| Revenue / Employee | ≈$22.0K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-191.8%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2022 | $-200.00 | $-30.60 | -553.6% | |
| March 31, 2022 | $-300.00 | $-234.60 | -27.9% | |
| Dec. 31, 2021 | $-500.00 | $-336.60 | -48.5% | |
| Sept. 30, 2021 | $-500.00 | $-210.80 | -137.2% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $286.0K | $8M | $7M | $62M | $86M | $64M | $6M | $8M | $4M | $101.0K | |
| Cost of Revenue | · | $3M | $3M | $33M | $49M | $37M | $2M | $3M | $2M | · | |
| Gross Profit | · | $5M | $3M | $28M | $36M | $27M | $4M | $6M | $2M | $101.0K | |
| R&D Expense | $2M | $2M | $4M | $7M | $29M | $16M | $17M | $25M | $33M | $25M | |
| SG&A Expense | $6M | $5M | $6M | $29M | $32M | $25M | $11M | $8M | $8M | $4M | |
| Operating Income | $-8M | $-6M | $-10M | $-43M | $-81M | $-64M | $-43M | $-39M | $-52M | $-31M | |
| Interest Expense | $1M | $2M | $9M | $42M | $17M | $13M | $438.0K | $167.0K | $77.0K | $375.0K | |
| Interest Income | $1M | $8M | $301.0K | $14M | $51.0K | $270.0K | $1M | $678.0K | $7M | $2M | |
| Net Income | $-429.0K | $-8M | $24M | $-72M | $-98M | $-76M | $-42M | $-39M | $-46M | $-29M | |
| EPS (Basic) | $0.00 | $0.00 | $0.01 | $-0.12 | $-0.21 | $-0.21 | $-0.14 | $-0.17 | $-0.26 | $-0.23 | |
| EPS (Diluted) | $0.00 | $0.00 | $0.01 | $-0.12 | $-0.21 | $-0.21 | $-0.14 | $-0.17 | $-0.26 | $-0.24 | |
| Shares (Basic) | 31,591,752,000 | 12,322,721,000 | 2,591,222,000 | 616,299,000 | 465,273,000 | 364,276,000 | 296,922,000 | 231,204,000 | 176,579,000 | 128,514,000 | |
| Shares (Diluted) | · | · | · | · | · | · | · | 231,204,000 | 176,579,000 | 128,809,000 | |
| EBITDA | $-8M | $-15M | $13M | $-43M | $-81M | $-64M | $-43M | $-39M | $-52M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1M | $2M | $6M | $13M | $29M | $14M | $6M | $8M | $8M | $54M | |
| Receivables | · | $3M | $3M | $35M | $32M | $29M | $1M | $958.0K | $2M | $99.0K | |
| Inventory | · | $4M | $4M | $11M | $15M | $7M | $2M | $769.0K | $653.0K | · | |
| Current Assets | $7M | $12M | $16M | $86M | $89M | $70M | $53M | $57M | $52M | $68M | |
| PP&E (Net) | $49.0K | $135.0K | $193.0K | $502.0K | $572.0K | $511.0K | $228.0K | $163.0K | $230.0K | $165.0K | |
| Intangibles | $5M | $6M | $6M | $66M | $72M | $88M | $17M | $5M | $5M | $6M | |
| Total Assets | $25M | $18M | $23M | $159M | $181M | $180M | $74M | $62M | $57M | $74M | |
| Accounts Payable | $731.0K | $1M | $3M | $4M | $12M | $12M | $4M | $3M | $5M | $60.0K | |
| Current Liabilities | $19M | $22M | $20M | $197M | $81M | $73M | $11M | $10M | $12M | $5M | |
| Total Liabilities | $21M | $23M | $21M | $207M | $172M | $166M | $14M | $11M | $12M | $12M | |
| Retained Earnings | $-414M | $-415M | $-408M | $-434M | $-368M | $-280M | $-208M | $-169M | $-133M | $-90M | |
| Stockholders' Equity | $4M | $-5M | $2M | $-48M | $9M | $14M | $60M | $51M | $45M | $63M |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-10M | $-9M | $-36M | $-29M | $-65M | $-49M | $-41M | $-34M | $-45M | $-28M | |
| CapEx | $5.0K | $9.0K | $11.0K | $198.0K | $115.0K | $406.0K | $168.0K | $23.0K | $146.0K | $85.0K | |
| Investing Cash Flow | $2M | $-9.0K | $4.0K | $8M | $-8M | $-36M | $5M | $5M | $-19M | $24M | |
| Financing Cash Flow | $7M | $8M | $21M | $11M | $73M | $84M | $36M | $42M | $26M | $36M | |
| Free Cash Flow | $-10M | $-9M | $-36M | $-29M | $-65M | $-49M | $-41M | $-34M | $-45M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 60.3% | 47.0% | 46.1% | 42.4% | 42.7% | 64.1% | 66.1% | 46.9% | · | |
| Operating Margin | -2776.9% | -181.7% | 193.5% | -69.3% | -94.6% | -99.0% | -686.7% | -470.5% | -1297.0% | · | |
| Net Margin | -150.0% | -102.8% | 366.2% | -116.0% | -114.0% | -118.4% | -672.5% | -464.4% | -1136.6% | · | |
| EBITDA Margin | -2776.9% | -181.7% | 193.5% | -69.3% | -94.6% | -99.0% | -686.7% | -470.5% | -1297.0% | · | |
| ROA | -2.0% | -40.2% | 26.3% | -42.1% | -54.1% | -59.9% | -62.0% | -64.8% | -69.2% | · | |
| ROE | 206.8% | 632.6% | -103.2% | 362.6% | -859.7% | -206.2% | -76.1% | -80.7% | -84.5% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.3 | 0.5 | 0.8 | 0.4 | 1.1 | 1.0 | 5.0 | 5.5 | 4.4 | · | |
| Quick Ratio | 0.1 | 0.2 | 0.4 | 0.2 | 0.7 | 0.6 | 0.7 | 0.8 | 0.8 | · | |
| Interest Coverage | -5.5 | -7.1 | 1.3 | -1.0 | -4.9 | -5.0 | -98.6 | -235.5 | -675.0 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.4 | 0.1 | 0.4 | 0.5 | 0.5 | 0.1 | 0.1 | 0.1 | · | |
| Inventory Turnover | · | 0.8 | 0.4 | 2.6 | 4.6 | 8.8 | 1.7 | 4.0 | 6.5 | · | |
| Receivables Turnover | · | 3.1 | 0.4 | 1.9 | 2.8 | 4.3 | 5.8 | 6.7 | 4.9 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | · | · | · | · | · | · | · | $0.04 | $0.02 | · | |
| Cash Flow / Share | · | · | · | · | · | · | · | $-0.15 | $-0.25 | · | |
| EPS (TTM) | $0.00 | $0.00 | $0.01 | $-0.12 | $-0.21 | $-0.21 | $-0.14 | $-0.17 | $-0.26 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $286.0K | $8M | $7M | $62M | $86M | $64M | $6M | $8M | $4M | · | |
| Net Income TTM | $-429.0K | $-8M | $24M | $-72M | $-98M | $-76M | $-42M | $-39M | $-46M | · | |
| P/E | · | · | 3650.0 | -1166.7 | -12285.7 | -38476.2 | -43357.1 | -32647.1 | -19769.2 | · | |
| Earnings Yield | 0.00% | 0.00% | 0.03% | -0.09% | -0.01% | 0.00% | 0.00% | 0.00% | -0.01% | · |
Per Share
| Metric | Trend | Q4 2018 | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 |
|---|---|---|---|---|---|---|---|
| EPS (TTM) | $-0.17 | $-0.24 | $-0.19 | · | · | · |
Valuation (TTM)
| Metric | Trend | Q4 2018 | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $101.0K | $3.0K | · | · | · | |
| Net Income TTM | $-39M | $-29M | $-21M | · | · | · | |
| P/E | -32647.1 | -43583.3 | -67789.5 | · | · | · | |
| Earnings Yield | 0.00% | 0.00% | 0.00% | · | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $286.0K | $8M | $7M | $62M | $86M |
| Gross Margin % | · | 60.3% | 47.0% | 46.1% | 42.4% |
| Operating Margin % | -2776.9% | -181.7% | 193.5% | -69.3% | -94.6% |
| Net Income | $-429.0K | $-8M | $24M | $-72M | $-98M |
| Diluted EPS | $0.00 | $0.00 | $0.01 | $-0.12 | $-0.21 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 0.3 | 0.5 | 0.8 | 0.4 | 1.1 |
| Quick Ratio | 0.1 | 0.2 | 0.4 | 0.2 | 0.7 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-10M | $-9M | $-36M | $-29M | $-65M |
Institutional owners (13F) 14 filers · $270K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
14
Value held
$270K
New positions
2
Exited positions
4
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 2 (-1 vs prior Q) | 4 (0 vs prior Q) | 5 (0 vs prior Q) | 2 (+1 vs prior Q) | -203K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Yorkville Advisors Global, LP | $106,681 | 122,131 | 39.50% | Shares |
| GAGNON SECURITIES LLC | $74,702 | 88,405 | 27.66% | Shares |
| CITADEL ADVISORS LLC | $55,196 | 65,321 | 20.44% | Shares |
| RHUMBLINE ADVISERS | $11,620 | 13,755 | 4.30% | Shares |
| Lido Advisors, LLC | $9,303 | 11,009 | 3.44% | Shares |
| GAMMA Investing LLC | $5,879 | 6,957 | 2.18% | Shares |
| CITIGROUP INC | $3,699 | 4,378 | 1.37% | Shares |
| Federation des caisses Desjardins du Quebec | $2,863 | 3,388 | 1.06% | Shares |
| UBS Group AG | $85 | 100 | 0.03% | Shares |
| SBI Securities Co., Ltd. | $13 | 15 | 0.00% | Shares |
| Smartleaf Asset Management LLC | $4 | 5 | 0.00% | Shares |
| Vermillion Wealth Management, Inc. | $2 | 2 | 0.00% | Shares |
| MORGAN STANLEY | $1 | 1 | 0.00% | Shares |
| ROYAL BANK OF CANADA | $0 | 351 | 0.00% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Quintairos, Prieto, Wood & Boyer P.A. | Aug. 7, 2024 | 0.00% | Initial filing | · | SEC |
| Dr. Shmuel Cabilly ×3 filings | Feb. 16, 2016 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 1 insider · 1 officers · 0 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Gilead Raday | Chief Operating Officer | July 10, 2026 M | 218,780,000 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
RDHL Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 7 analysts
BUY
2 28.6%
Strong Buy
4 57.1%
Buy
1 14.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Apr 27, 2026